Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.

Tran, Duy C

Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma. [electronic resource] - JAMA dermatology 01 2017 - 92-94 p. digital

Publication Type: Letter

2168-6084

10.1001/jamadermatol.2016.3884 doi


Aged
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Antineoplastic Agents, Immunological--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cell Death
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Middle Aged
Nivolumab
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Skin Neoplasms--drug therapy
Time Factors
Treatment Outcome